Dr. Sandeep Singh Sidhu is a leading Gastroenterologist and Hepatologist from Ludhiana, Punjab specialising in Hepatic Encephalopathy, Alcoholic Hepatitis and Hepatorenal Syndrome. He has vast expertise and experience in Treatment of Liver Disease and has successfully treated high volume of patients in his 20 years of medical practice.

Post completion of MBBS in 1984 and MD (Medicine) in 1989 from Christian Medical College, Ludhiana, he accomplished Doctor of... [+]

Fellowships
  • Fellow: Liver Transplantation & Clinical Hepatology, Addenbrookes's Hospital, Cambridge, UK 2010.
  • Fellow: Deutscher Akademischer Austauschdienst Fellowship (DAAD) Fellowship, University of Eppendorf, Hamburg, Germany 1998.
  • Visiting Clinician- Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA from 25th January to 29th January 2016.
[+]
Accreditation
  • Life Member: Indian Society of Gastroenterology.
  • Life Member: Indian Association for the study of Liver.
  • Member: American College of Gastroenterology (MACG)

[+]

Testimonials

Research
Minimal Hepatic Encephalopathy: To compare the efficacy of rifaximin and lactulose in improving minimal hepatic encephalopathy in patients with cirrhosis: a single blind, randomised, active-comparator, non-inferiority trial (ALARM TRIAL: Active Comparator Trial of Lactulose & Rifaximin  in MHE). (American Journal of Gastroenterology: IN PRESS).
Hepato-Renal Syndrome Type I: Comparison of Intravenous Nor-Adrenaline and albumin versus Intravenous Terlipressin  and Albumin in the Treatment of Type I Hepato-Renal Syndrome , in Cirrhosis. An open label randomised prospective trial. This trial is under consideration of an International Medical Journal.
Overt Hepatic Encephalopathy: “Efficacy Of Intravenous L-Ornithine And L-Aspartate In Patients Of Overt Acute Hepatic Encephalopathy”. This multicenter trial (involving Dayanand Medical College & Hospital, Ludhiana and G.B. Pant Hospital, N.Delhi is registered and  enrolling patients.
[+]
Publications
Article
Efficacy of intravenous ‘l-ornithine l aspartate’ in reversal of overt acute hepatic encephalopathy in patients with liver cirrhosis: a prospective, randomized, double-blind placebo controlled trail” (Recruiting).
Article
Sorafenib induced Acute Overt Hepatic Encephalopathy (In Press).
Article
Efficacy of oral glucocorticoids and oral bovine colostrum in the treatment of “Alcoholic Hepatitis in Extremis”. (Proof of Concept Trial) (Completed Recruitment and follow up in progress).
[+]